Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement

被引:0
|
作者
Verdecia M.A. [1 ,2 ]
Huang H.-K. [3 ]
Dutil E. [1 ]
Kaiser D.A. [1 ]
Hunter T. [3 ]
Noel J.P. [1 ]
机构
[1] Structural Biology Laboratory, University of California, San Diego, San Diego
[2] Department of Biology, University of California, San Diego, San Diego
[3] Molec. Biol. and Virology Laboratory, Salk Inst. for Biol. Studies, San Diego
基金
美国国家卫生研究院;
关键词
D O I
10.1038/76838
中图分类号
学科分类号
摘要
Survivin is a 16.5 kDa protein that is expressed during the G2/M phase of the cell cycle and is hypothesized to inhibit a default apoptotic cascade initiated in mitosis. This inhibitory function is coupled to survivin's localization to the mitotic spindle. To begin to address the structural basis of survivin's function, we report the X-ray crystal structure of a recombinant form of full length survivin to 2.58 Å resolution. Survivin consists of two defined domains including an N-terminal Zn2+-binding BIR domain linked to a 65 Å amphipathic C-terminal α-helix. The crystal structure reveals an extensive dimerization interface along a hydrophobic surface on the BIR domain of each survivin monomer. A basic patch acting as a sulfate/phosphate-binding module, an acidic cluster projecting off the BIR domain, and a solvent-accessible hydrophobic surface residing on the C- terminal amphipathic helix, are suggestive of functional protein-protein interaction surfaces.
引用
收藏
页码:602 / 608
页数:6
相关论文
共 50 条
  • [21] The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells
    Blum, Barak
    Bar-Nur, Ori
    Golan-Lev, Tamar
    Benvenisty, Nissim
    NATURE BIOTECHNOLOGY, 2009, 27 (03) : 281 - 287
  • [22] Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
    Zaffaroni, N
    Pennati, M
    Colella, G
    Perego, P
    Supino, R
    Gatti, L
    Pilotti, S
    Zunino, F
    Daidone, MG
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (08) : 1406 - 1412
  • [23] Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
    N. Zaffaroni
    M. Pennati
    G. Colella
    P. Perego
    R. Supino
    L. Gatti
    S. Pilotti
    F. Zunino
    M. G. Daidone
    Cellular and Molecular Life Sciences CMLS, 2002, 59 : 1406 - 1412
  • [24] The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells
    Barak Blum
    Ori Bar-Nur
    Tamar Golan-Lev
    Nissim Benvenisty
    Nature Biotechnology, 2009, 27 : 281 - 287
  • [25] Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin
    Song, Z
    Wu, M
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 133A - 133A
  • [26] Leptin induces migration of breast cancer cells via upregulation of anti-apoptotic protein, survivin
    Knight, Brandi Brandon
    Oberlick, Elaine
    Nagalingam, Arumugam
    Taliaferro-Smith, LaTonia
    Karna, Prashanti
    Yang, Lily
    Saxena, Neeraj
    Sharma, Dipali
    CANCER RESEARCH, 2009, 69
  • [27] The 5′ untranslated region of the anti-apoptotic protein Survivin contains an inhibitory upstream AUG codon
    Palavecino, Christian E.
    Carrasco-Veliz, Nicolas
    Quest, Andrew F. G.
    Garrido, Maritza P.
    Valenzuela-Valderrama, Manuel
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 526 (04) : 898 - 905
  • [28] Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic 190 proteins
    Obiol-Pardo, Cristian
    Granadino-Roldan, Jose Manuel
    Rubio-Martinez, Jaime
    JOURNAL OF MOLECULAR RECOGNITION, 2008, 21 (03) : 190 - 204
  • [29] Expression of anti-apoptotic protein survivin and tumor suppressor p53 protein in patients with pulmonary carcinoma
    Halasová E.
    Adamkov M.
    Kavcová E.
    Matáková T.
    Musák L.
    Vybohová D.
    Janícková M.
    Mistuna D.
    Singliar A.
    European Journal of Medical Research, 14 (Suppl 4) : 97 - 100
  • [30] EXPRESSION OF ANTI-APOPTOTIC PROTEIN SURVIVIN AND TUMOR SUPPRESSOR p53 PROTEIN IN PATIENTS WITH PULMONARY CARCINOMA
    Halasova, E.
    Adamkov, M.
    Kavcova, E.
    Matakova, T.
    Musak, L.
    Vybohova, D.
    Janickova, M.
    Mistuna, D.
    Singliar, A.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 97 - 100